SWM
AGIO icon

Spire Wealth Management’s Agios Pharmaceuticals AGIO Stock Holding History

Spire Wealth Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-230
Closed -$9.23K – 2300
2025
Q3 		$9.23K Hold
230
– – ﹤0.01% 1776
2025
Q2 		$7.65K Hold
230
– – ﹤0.01% 1812
2025
Q1 		$6.74K Hold
230
– – ﹤0.01% 1974
2024
Q4 		$7.56K Hold
230
– – ﹤0.01% 1924
2024
Q3 		$10.2K Hold
230
– – ﹤0.01% 1623
2024
Q2 		$9.92K Hold
230
– – ﹤0.01% 1637
2024
Q1 		$6.72K Hold
230
– – ﹤0.01% 1850
2023
Q4 		$5K Hold
230
– – ﹤0.01% 1955
2023
Q3 		$5.69K Hold
230
– – ﹤0.01% 1910
2023
Q2 		$6.51K Hold
230
– – ﹤0.01% 1935
2023
Q1 		$5.28K Buy
+230
New +$6.11K ﹤0.01% 2021
2022
Q3 		– Sell
-45
Closed -$1K – 2174
2022
Q2 		$1K Hold
45
– – ﹤0.01% 2450
2022
Q1 		$1K Sell
45
-243
-84% -$7.42K ﹤0.01% 2449
2021
Q4 		$9K Buy
288
+243
+540% +$9.78K ﹤0.01% 2402
2021
Q3 		$2K Hold
45
– – ﹤0.01% 2444
2021
Q2 		$2K Sell
45
-230
-84% -$12.9K ﹤0.01% 2460
2021
Q1 		$14K Buy
+275
New +$13.6K ﹤0.01% 2285

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Spire Wealth Management's AGIO Position: Q4 2025 in Review

Spire Wealth Management sold out of Agios Pharmaceuticals (AGIO) in Q4 2025, closing a stake of 230 shares — an estimated $9.23K sold.

Spire Wealth Management first reported a position in AGIO in Q1 2021 and held it in 17 quarters. The position peaked at $14K in Q1 2021. 238 funds tracked by Wall St. Rank hold AGIO as of Q4 2025.

  • Spire Wealth Management reported no remaining Agios Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Spire Wealth Management sold 230 Agios Pharmaceuticals shares in Q4 2025, an estimated $9.23K.
  • Spire Wealth Management first reported a position in Agios Pharmaceuticals in Q1 2021 and held it in 17 quarters.
  • Spire Wealth Management's Agios Pharmaceuticals position peaked at $14K in Q1 2021.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2025.

Based on Spire Wealth Management's 13F filing for Q4 2025, filed 14 Jan 2026.